• $320,570.00
    Market Cap
  • 0.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
312,500
N/A
N/A
N/A
N/A
N/A
7,305
N/A
Total Operating Expenses
2.0M
-41.63%
3.4M
-42.64%
5.9M
+2,268.34%
248,115
N/A
Operating Profit
-2.0M
-41.63%
-3.4M
-42.64%
-5.9M
+2,268.34%
-248,115
N/A
Interest Income
3,373
-53.26%
7,216
N/A
N/A
N/A
N/A
N/A
Interest Expense
-360,788
N/A
N/A
N/A
-41,986
-91.98%
-523,283
N/A
Interest Income and Expense and Net
-357,415
-5,053.09%
7,216
+117.19%
-41,986
-91.98%
-523,283
N/A
Total Nonoperating Income and Expense
-1.3M
-18,035.20%
7,216
-99.98%
43.4M
+194.18%
-46.0M
N/A
Income before Taxes
-3.3M
-3.03%
-3.4M
-108.98%
37.5M
+180.98%
-46.3M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
624,289
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-3.3M
-3.03%
-3.4M
-108.98%
37.5M
+180.98%
-46.3M
N/A
Net Income from Continuing Operations Applicable to Common
-3.3M
-3.03%
-3.4M
-108.98%
37.5M
+180.98%
-46.3M
N/A
Basic EPS and Net Income
0.00
N/A
0.00
-100.00%
0.02
+111.76%
-0.17
N/A
Diluted EPS and Net Income
0.00
N/A
0.00
N/A
0.00
+100.00%
-0.17
N/A
Basic Weighted Average Shares
2.9B
+9.96%
2.6B
+8.37%
2.4B
+815.21%
267.2M
N/A
Diluted Weighted Average Shares
3.0B
+13.27%
2.6B
+4.28%
2.5B
+851.12%
267.2M
N/A
Balance Sheet
Cash and Cash Equivalents
0
-100.00%
226,231
-2.84%
232,850
+19,191.63%
1,207
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
0
-100.00%
226,231
-2.84%
232,850
+19,191.63%
1,207
N/A
Total Current Assets
37,418
-91.38%
433,904
+84.17%
235,601
+7,541.94%
3,083
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
53,402
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
37,418
-93.54%
578,904
+145.71%
235,601
+7,541.94%
3,083
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
471,094
+1,613.07%
27,500
N/A
N/A
N/A
123,200
N/A
Total Current Liabilities
1.3M
+468.64%
233,378
+61.61%
144,404
-99.68%
44.8M
N/A
Total Long-Term Debt
N/A
N/A
10,000
N/A
N/A
N/A
246,400
N/A
Total Long-Term Liabilities
0
N/A
0
-100.00%
250,783
-94.24%
4.4M
N/A
Total Liabilities
1.3M
+468.64%
233,378
+61.61%
144,404
-99.68%
44.8M
N/A
Retained Earnings
-30.3M
+12.05%
-27.1M
+14.20%
-23.7M
-61.26%
-61.2M
N/A
Total Stockholders Equity
-1.3M
-473.25%
345,526
+278.88%
91,197
+100.20%
-44.7M
N/A
Total Shares Outstanding
3.1B
+15.32%
2.7B
+4.55%
2.6B
+7.27%
2.4B
N/A
Cash Flow
Cash from Operating Activities
-518,941
-40.87%
-877,619
+158.00%
-340,157
+1,849.10%
-17,452
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-479,289
+57.14%
-305,000
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
772,000
-34.35%
1.2M
+105.67%
571,800
+8,967.55%
6,306
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-1,058.41%
+28.15%
-825.92%
-102.63%
31,403.22%
+109.52%
-329,729.09%
N/A
Return on Equity
690.92%
+144.85%
-1,540.38%
+817.77%
-167.84%
-188.95%
188.69%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.03
-98.48%
1.86
+13.96%
1.63
+1,631,400.00%
0.0001
N/A
Cash Ratio
0.00
-100.00%
0.97
-39.88%
1.61
N/A
0.00
N/A
Debt-to-Equity Ratio
N/A
N/A
0.11
N/A
N/A
N/A
-0.008
N/A
Debt-to-Assets Ratio
N/A
N/A
0.06
N/A
N/A
N/A
119.88
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow